ctrl K

Maravai LifeSciences Inc... (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

2.04

0.02 (0.99%)

At close: May 01, 2025, 3:59 PM

2.04

0.25%

Pre-market: May 02, 2025, 08:49 AM EDT

Maravai LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	259.19M	288.94M	883M	799.24M	284.1M	143.14M	123.83M
Cost of Revenue	150.88M	148.74M	168.96M	140.56M	79.65M	66.85M	60.77M
Gross Profit	108.31M	140.2M	714.04M	658.68M	204.45M	76.29M	63.07M
Operating Income	-235.62M	-31.65M	574.22M	554.64M	67.6M	23.99M	16.44M
Interest Income	27.4M	27.73M	2.34M	30.26M	30.74M	29.96M	n/a
Pretax Income	-261.48M	617.74M	551.47M	530.76M	81.7M	-5.85M	-16.5M
Net Income	-144.85M	-119.03M	490.66M	469.25M	76.89M	-5.2M	-17.73M
Selling & General & Admin	161.77M	151.39M	129.26M	100.06M	94.25M	48.35M	41.19M
Research & Development	19.22M	17.28M	18.37M	15.22M	9.3M	3.63M	4.5M
Other Expenses	162.93M	3.18M	-358K	279K	-7.47M	118K	87K
Operating Expenses	343.93M	171.85M	147.63M	115.28M	103.55M	51.98M	45.69M
Interest Expense	47.7M	45.89M	20.41M	30.26M	30.74M	29.96M	27.4M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	494.8M	320.59M	316.58M	255.84M	183.2M	118.83M	106.46M
Income Tax Expense	-1.86M	756.11M	60.81M	61.52M	2.88M	-652K	417K
Shares Outstanding (Basic)	137.91M	131.92M	131.54M	114.79M	96.65M	96.65M	88.97M
Shares Outstanding (Diluted)	137.91M	131.92M	255.32M	257.8M	96.65M	96.65M	88.97M
EPS (Basic)	-1.05	-0.9	3.73	4.09	0.80	-0.05	-0.2
EPS (Diluted)	-1.05	-0.9	1.92	1.82	0.70	-0.05	-0.2
EBITDA	-156.92M	712.41M	609.99M	585.78M	138.27M	48.19M	33.25M
EBIT	-213.78M	663.63M	571.89M	561.02M	112.44M	24.11M	10.9M
Depreciation & Amortization	56.87M	48.78M	38.1M	24.75M	25.84M	24.08M	22.35M